核梭杆菌
下调和上调
转录组
结直肠癌
细胞
癌症
生物
细胞外
细菌
癌症研究
细胞生物学
癌细胞
肿瘤微环境
肿瘤进展
微生物学
生物膜
梭杆菌
上皮
作者
Jorge Luis Galeano Niño,Falk Ponath,Victor A. Ajisafe,Clara R. Becker,Andrew G. Kempchinsky,Martha A. Zepeda‐Rivera,Javier A. Gomez,Hanrui Wu,Jessica G Terrazas,Heather K. Bouzek,Elizabeth A. Cromwell,Pritha Chanana,Matthew Wong,Ashish V. Damania,Michael Geoffrey White,Y. Nancy You,Scott Kopetz,Nadim J. Ajami,Jennifer Ann Wargo,Christopher D. Johnston
出处
期刊:Cancer Cell
[Cell Press]
日期:2025-10-16
卷期号:44 (1): 166-186.e16
被引量:57
标识
DOI:10.1016/j.ccell.2025.09.010
摘要
Tumor-infiltrating bacteria are increasingly recognized as modulators of cancer progression and therapy resistance. We describe a mechanism by which extracellular intratumoral bacteria, including Fusobacterium, modulate cancer epithelial cell behavior. Spatial imaging and single-cell spatial transcriptomics show that these bacteria predominantly localize extracellularly within tumor microniches of colorectal and oral cancers, characterized by reduced cell density, transcriptional activity, and proliferation. In vitro, Fusobacterium nucleatum disrupts epithelial contacts, inducing G0-G1 arrest and transcriptional quiescence. This state confers 5-fluorouracil resistance and remodels the tumor microenvironment. Findings were validated by live-cell imaging, spatial profiling, mouse models, and a 52-patient colorectal cancer cohort. Transcriptomics reveals downregulation of cell cycle, transcription, and antigen presentation genes in bacteria-enriched regions, consistent with a quiescent, immune-evasive phenotype. In an independent rectal cancer cohort, high Fusobacterium burden correlates with reduced therapy response. These results link extracellular bacteria to cancer cell quiescence and chemoresistance, highlighting microbial-tumor interactions as therapeutic targets.
科研通智能强力驱动
Strongly Powered by AbleSci AI